# MRPL-019 - Review Validation Results

- Owner role: Quant Researcher / QA Lead
- Status: done
- Lifecycle state: Completed
- Risk lane: normal
- Canonical artifact: `docs/validation-review.md`

## Scope

Review the MRPL-018 locked validation results and decide the next methodology
direction.

The validation run is a partial pass: it beats equal weight but does not clear
the full benchmark panel because SHY has slightly higher validation Sharpe and
much lower drawdown.

## Acceptance Criteria

- Summarize what passed and failed under `docs/validation-protocol.md`.
- Explain why the result should remain diagnostic and not claim-grade.
- Review the high validation turnover for the selected configuration.
- Decide whether next work should focus on benchmark panel refinement,
  turnover constraints, regime definition, or allocation-rule simplicity.
- Preserve negative or partial validation evidence in the public docs.

## Verification Evidence

- Created `docs/validation-review.md`.
- Summarized MRPL-018 locked validation as a partial pass: beats equal weight and static 60/40, but does not clear SHY on Sharpe/drawdown.
- Preserved claim boundary: no robust outperformance, no validated strategy, no tradeable-signal language.
- Reviewed turnover issue: selected configuration had 0.0991 average monthly turnover in the research window but 0.2304 in the locked validation window.
- Decided next methodology priority: allocation-rule simplicity and turnover stability before benchmark-panel changes or further regime definition work.
- Added README pointer to the validation review.
- Created MRPL-020 next work order.

## Blocker / Decision Needed

- None.

## Closeout State

- Completed. Next work should design a second-cycle protocol focused on turnover stability and allocation-rule simplicity.
